Insider Selling: Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells 15,713 Shares of Stock

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 15,713 shares of the firm’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $2.56, for a total value of $40,225.28. Following the completion of the transaction, the director now owns 2,805,682 shares in […]

Related Keywords

United States ,Suzanne Ildstad ,Charles Schwab Investment Management Inc ,Talaris Therapeutics Company Profile ,Nasdaq ,Goldman Sachs Group Inc ,Securities Exchange Commission ,Jpmorgan Chase Co ,Deutsche Bank ,Talaris Therapeutics Inc ,Barclays Plc ,Morgan Stanley ,Talaris Therapeutics ,Get Rating ,Director Suzanne Ildstad ,Exchange Commission ,Sachs Group ,Schwab Investment Management ,Talaris Therapeutics Daily ,Nasdaq Tals ,Metals ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,